Rafael da Fonseca Lameiro (Rafael F Lameiro)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Machine Learning

Trypanosoma Cruzi

Top Venues

Expert opinion on therapeutic patents

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem (2023)
Rafael da Fonseca Lameiro, Carlos Alberto Montanari
Investigating the Lack of Translation from Cruzain Inhibition to Trypanosoma cruzi Activity with Machine Learning and Chemical Space Analyses. ChemMedChem 18 (6) (2023)
Fernanda R Rocho, Vinícius Bonatto, Rafael da Fonseca Lameiro, Jeronimo Lameira, Andrei Leitão, Carlos Alberto Montanari
A patent review on cathepsin K inhibitors to treat osteoporosis (2011 - 2021). Expert opinion on therapeutic patents 32 (5) (2022)
Rafael da Fonseca Lameiro, Anwar Shamim, Fabiana Rosini, Rodrigo Cendron, Pedro Henrique Jatai Batista, Carlos Alberto Montanari
Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds. Future medicinal chemistry 13 (1) (2020)